Catalyst Wire Dossier Catalyst Wire Dossier

rhPTH(1-34) recombinant human

parathyroid hormone analog, 1-34 fragment
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rhPTH(1-34) recombinant human, covering 2021-06-28 to 2021-06-28. Get the full timeline:

Most recent: Clinical Trial Update: Recombinant Human rhPTH(1-34) VS Association Alfacalcidol/Hydrochlorothiazide in Severe Primary Hypoparathyroidism [Phase 2]

See pricing